Avidity Biosciences Inc (RNA)
52.23
-0.32
(-0.61%)
USD |
NASDAQ |
Nov 14, 10:32
Avidity Biosciences 1 Year Total Returns (Daily): 817.1% for Nov. 13, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 13, 2024 | 817.1% |
November 12, 2024 | 752.7% |
November 11, 2024 | 759.9% |
November 08, 2024 | 762.0% |
November 07, 2024 | 714.9% |
November 06, 2024 | 791.3% |
November 05, 2024 | 724.3% |
November 04, 2024 | 719.4% |
November 01, 2024 | 717.8% |
October 31, 2024 | 720.6% |
October 30, 2024 | 749.1% |
October 29, 2024 | 815.2% |
October 28, 2024 | 838.8% |
October 25, 2024 | 793.3% |
October 24, 2024 | 760.0% |
October 23, 2024 | 800.8% |
October 22, 2024 | 779.0% |
October 21, 2024 | 766.6% |
October 18, 2024 | 786.6% |
October 17, 2024 | 702.0% |
October 16, 2024 | 710.3% |
October 15, 2024 | 655.7% |
October 14, 2024 | 655.8% |
October 11, 2024 | 619.1% |
October 10, 2024 | 544.6% |
Date | Value |
---|---|
October 09, 2024 | 644.1% |
October 08, 2024 | 648.5% |
October 07, 2024 | 610.0% |
October 04, 2024 | 725.5% |
October 03, 2024 | 652.8% |
October 02, 2024 | 693.3% |
October 01, 2024 | 660.3% |
September 30, 2024 | 619.9% |
September 27, 2024 | 555.3% |
September 26, 2024 | 561.0% |
September 25, 2024 | 629.4% |
September 24, 2024 | 582.2% |
September 23, 2024 | 574.4% |
September 20, 2024 | 530.0% |
September 19, 2024 | 525.3% |
September 18, 2024 | 541.2% |
September 17, 2024 | 501.9% |
September 16, 2024 | 495.6% |
September 13, 2024 | 486.6% |
September 12, 2024 | 473.0% |
September 11, 2024 | 517.0% |
September 10, 2024 | 499.0% |
September 09, 2024 | 498.5% |
September 06, 2024 | 483.0% |
September 05, 2024 | 447.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-69.87%
Minimum
Sep 08 2023
838.8%
Maximum
Oct 28 2024
47.12%
Average
-20.57%
Median
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | 41.18% |
Natera Inc | 231.5% |
Entrada Therapeutics Inc | 21.87% |
Alnylam Pharmaceuticals Inc | 60.28% |
Catalyst Pharmaceuticals Inc | 80.52% |